Skip to main content

Together we are beating cancer

Donate now

Cancer type

Showing 12 out of 2908 results
Microscopic image of core biopsy for infiltrating (invasive) ductal carcinoma, detected by screening mammogram

Our researchers have published a paper showing that their alternative BRCA testing pathway, BRCA-DIRECT, could be a more convenient way to test for faulty BRCA genes in people with breast cancer Our researchers have published a paper showing that their alternative BRCA testing pathway, BRCA-DIRECT, could be a more convenient way to test for faulty BRCA genes in people with breast cancer

by Fiona Scott | News | 1 October 2024

1 October 2024

Radiographer looking at a mammogram image

Since the discovery of the BRCA genes 30 years ago, we’ve made huge leaps forward in understanding faulty BRCA-driven cancers – leaps that are saving and improving lives right now​. Since the discovery of the BRCA genes 30 years ago, we’ve made huge leaps forward in understanding faulty BRCA-driven cancers – leaps that are saving and improving lives right now​.

by Amy Warnock | In depth | 1 October 2024

1 October 2024

Caitlin, who was diagnosed with Ewing sarcoma this year and is going to take part in our INTER-EWING-1 trial.

INTER-EWING-1, the largest and most ambitious study ever conducted into Ewing sarcoma, could transform how we treat the disease, which mainly affects children and young people.   INTER-EWING-1, the largest and most ambitious study ever conducted into Ewing sarcoma, could transform how we treat the disease, which mainly affects children and young people.  

by Momoko Bowles | Analysis | 25 September 2024

25 September 2024

CT scan of a glioblastoma brain tumour highlighted in one section of the brain.

Brain tumour survival remains low and current treatments can have life-altering side effects. That's why Cancer Research UK is awarding £8m more to our Brain Tumour Centres of Excellence to accelerate our discovery of kinder and more effective treatments. Brain tumour survival remains low and current treatments can have life-altering side effects. That's why Cancer Research UK is awarding £8m more to our Brain Tumour Centres of Excellence to accelerate our discovery of kinder and more effective treatments.

by Sadaf Shafaghmotlagh | News | 24 September 2024

24 September 2024

A sample of a mouse model of a tumour seen through team Rosetta's tools.

Cancer Grand Challenges team Rosetta found how some of the most aggressive and hard-to-treat breast cancers get the energy they need to grow and spread so quickly. Now we can see about slowing them down for good. Cancer Grand Challenges team Rosetta found how some of the most aggressive and hard-to-treat breast cancers get the energy they need to grow and spread so quickly. Now we can see about slowing them down for good.

by Tim Gunn | In depth | 24 September 2024

24 September 2024

Researchers working in the lab at CRUK's Scotland Institute

Over the last financial year, Cancer Research UK has made significant steps towards achieving its vision of bringing about a world where everyone can live longer, better lives, free from the fear of cancer, as outlined in the charity’s latest Annual Report and Accounts, which were published today. Over the last financial year, Cancer Research UK has made significant steps towards achieving its vision of bringing about a world where everyone can live longer, better lives, free from the fear of cancer, as outlined in the charity’s latest Annual Report and Accounts, which were published today.

by Cancer Research UK | News | 11 September 2024

11 September 2024

Zhe Huang

We spoke to Dr Zhe Huang about his work investigating the proteomic profiles of prostate cancer... We spoke to Dr Zhe Huang about his work investigating the proteomic profiles of prostate cancer...

by Cancer Research UK | Interview | 10 September 2024

10 September 2024

A medical professional drawing a dose of a vaccine from a vial with a syringe

LynchVax could help prevent cancer in people with Lynch syndrome, who have a higher risk of bowel cancer, womb cancer and some other types. LynchVax could help prevent cancer in people with Lynch syndrome, who have a higher risk of bowel cancer, womb cancer and some other types.

by Tim Gunn | News | 10 September 2024

10 September 2024

scientists in a lab

Cancer Research UK and LifeArc are investing £27m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers. Cancer Research UK and LifeArc are investing £27m in funding and resources as part of a pioneering international initiative dedicated to developing new medicines exclusively for children’s and young people’s cancers.

by Sophie Wedekind | News | 5 September 2024

5 September 2024

Sânziana Foia in the lab with an image of Papcup, the new HPV test she has designed for cervical screening, on a laptop.

Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part.  Sânziana Foia is developing a cervical screening device designed to detect high-risk HPV in menstrual blood within minutes. It could help remove some of the biggest barriers to cervical screening, helping many more eligible people take part. 

by Sadaf Shafaghmotlagh | Analysis | 4 September 2024

4 September 2024

An image of Faye lying down in the proton beam therapy machine next to an image of her in hospital making decorations for a fundraising sale.

Clinical trials are how we bring better cancer treatments to children and young people. For Childhood Cancer Awareness Month, we asked parents what they're actually like. Clinical trials are how we bring better cancer treatments to children and young people. For Childhood Cancer Awareness Month, we asked parents what they're actually like.

by Tom Bourton, Tim Gunn | Personal stories | 3 September 2024

3 September 2024

Microscopy image of Hodgkin's lymphoma

Since the 1970s, our work has helped double children's cancer survival in the UK. Here are some of our biggest achievements from the last 50 years that wouldn't have been possible without the support of our partners and supporters. Since the 1970s, our work has helped double children's cancer survival in the UK. Here are some of our biggest achievements from the last 50 years that wouldn't have been possible without the support of our partners and supporters.

by Cancer Research UK | In depth | 3 September 2024

3 September 2024